FX-909
Not Tagged
['urothelial']
first preclinical data on fx-909, a novel small molecule pparg inhibitor for potential treatment of urothelial cancer, presented at the 2023 aacr annual meeting. more info: $xbi $ibb $xph $pph
Latest BioPharma/Biotech News. Daily $XBI $XPH Market Movers

Database: https://t.co/IBOqbSoYuc
Clinical trial tools: https://t.co/A77u9Q84Dc  https://t.co/lvTtwarrGT